A detailed history of Drw Securities, L.L.C. transactions in Repligen Corp stock. As of the latest transaction made, Drw Securities, L.L.C. holds 10,600 shares of RGEN stock, worth $1.53 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,600
Holding current value
$1.53 Million
% of portfolio
0.04%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Drw Securities, L.L.C. Portfolio

Follow Drw Securities, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, L.L.C. with notifications on news.